Emerging application of stereotactic body radiation therapy for gynecologic malignancies

Expert Review of Anticancer Therapy

Volumn 11, Issue 7, 2011, Pages 1071-1077

  Mayr, Nina A ^a   Huang, Zhibin ^b   Sohn, Jason W ^c   Lo, Simon S ^c   Teh, Bin S ^d   Lu, Jiade J ^e   Grecula, John C ^a   Kunos, Charles ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

gynecologic malignancies; radiation therapy; stereotactic

Indexed keywords

ADVERSE OUTCOME; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; GYNECOLOGIC CANCER; HUMAN; OUTCOME ASSESSMENT; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIOBIOLOGY; REVIEW; RISK ASSESSMENT; STEREOTACTIC BODY RADIATION THERAPY; THERAPY EFFECT; TREATMENT INDICATION;

EID: 79961051451     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.11.81     Document Type: Review

References (40)

1. Chang E, Shiu A, Mendel E et al. Phase I/ II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J. Neurosurg. Spine 7(2), 151-160 (2007). (Pubitemid 47219748)
2. Baumann P, Nyman J, Hoyer M et al. Outcome in a prospective Phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J. Clin. Oncol. 27(20), 3290-3296 (2009).
3. Schefter T, Kavanagh B, Timmerman R, Cardenes H, Baron A, Gaspar L. A Phase 1 trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int. J. Radiat. Oncol. Biol. Phys. 62(5), 1371-1378 (2005). (Pubitemid 40982057)
4. Kunos C, Von Gruenigen V, Waggoner S et al. Cyberknife radiosurgery for squamous cell carcinoma of the vulva after prior pelvic radiation therapy. Technol. Cancer Res. Treat. 7(5), 375-380 (2008).
5. Kunos C, Chen W, DeBernardo R et al. Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies. Technol. Cancer Res. Treat. 8(5), 393-400 (2009).
6. Molla M, Escude L, Nouet P et al. Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy? Int. J. Radiat. Oncol. Biol. Phys. 62(1), 118-124 (2005). (Pubitemid 40591932)
7. Jorcano S, Molla M, Escude L et al. Hypofractionated extracranial stereotactic radiotherapy boost for gynecologic tumors: a promising alternative to high-dose rate brachytherapy. Technol. Cancer Res. Treat. 9(5), 509-514 (2010).
8. Guckenberger M, Bachmann J, Wulf J et al. Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. Radiother. Oncol. 94(1), 53-59 (2010).
9. Choi C, Cho C, Yoo S et al. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int. J. Radiat. Oncol. Biol. Phys. 74(1), 147-153 (2009).
10. Kunos C, Brindle J, Zhang Y,DeBernardo R. A prospective Phase 2 evaluation of stereotactic body radiosurgery for gynecologic malignancies. Presented at: Cyberknife Robotic Radiosurgery Summit. San Francisco, CA, USA, 12 February 2011.
11. Munro T. The relative radiosensitivity of the nucleus and cytoplasm of the Chinese hamster fibroblast. Radiat. Res. 42, 451-470 (1970).
12. Park C, Papiez L, Zhang S, Story M, Timmerman R. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 70(3), 847-852 (2008). (Pubitemid 351199730)
13. Kavanagh B, Newman F. Toward a unified survival curve: in regard to Park et al. (Int. J. Radiat. Oncol. Biol. Phys. 2008;70:847-852
14. Krueger et al. (Int. J. Radiat. Oncol. Biol. Phys. 2007;69:1262-1271). Int. J. Radiat. Oncol. Biol. Phys. 71(3), 958-964 (2008).
15. Park C, Papiez L. In reply to Dr. Fowler and Dr. Kavanagh. Int. J. Radiat. Oncol. Biol. Phys. 72(3), 958 (2008).
16. Tome W. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy: in regard to Park et al. (Int. J. Radiat. Oncol. Biol. Phys. 2008;70: 847-852).Int. J. Radiat. Oncol. Biol. Phys. 72(5), 1620 (2008).
17. Wang J, Huang H, Lo S, Yuh W, Mayr N. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci. Transl. Med. 2(39), 39-48 (2010).
18. Hall EJ. Radiobiology for the Radiologist. Lippincott Williams & Wilkins, Philadelphia, PA, USA (2000).
19. Hall EJ, Hei TK. Genomic instability and bystander effects induced by high-LET radiation. Oncogene 22(45), 7034-7042 (2003). (Pubitemid 37386672)
20. + T cells: changing strategies for cancer treatment. Blood 114(3), 589-595 (2009).
21. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 8, 89-91 (2005). (Pubitemid 41132735)
22. Mackie T, Holmes T, Swerdloff S et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Medical Physics 20(6), 1709-1719 (1993). (Pubitemid 24001191)
23. Benedict S, Cardinale R, Wu Q, Zwicker R, Broaddus W, Mohan R. Intensitymodulated stereotactic radiosurgery using dynamic micro-multileaf collimation. Int. J. Radiat. Oncol. Biol. Phys. 50(3), 751-758 (2001). (Pubitemid 32515330)
24. Owen R, Kron T, Foroudi F et al. The detectability and localization accuracy of implanted fiducial markers determined on in-room computerized tomography (CT) and electronic portal images (EPI).Med. Dosim. 33(3), 226-233 (2008).
25. Wang J, Rice R, Mundt A, Sandhu A, Murphy K. Image-guided stereotactic spine radiosurgery on a conventional linear accelerator. Med. Dosim. 35(1), 53-62 (2010).
26. Gerszten P, Novotny JJ, Quader M, Dewald V, Flickinger J. Prospective evaluation of a dedicated spine radiosurgery program using the Elekta Synergy S system. J. Neurosurg. 113(Suppl.), 236-241 (2010).
27. Kilby W, Dooley J, Kuduvalli G, Sayeh S, Maurer C. The Cyberknife robotic radiosurgery system in 2010. Technol. Cancer Res. Treat. 9(5), 431-438 (2010).
28. Sherouse G, Bourland J, Reynolds K et al. Virtual simulation in the clinical setting: some practical considerations. Int. J. Radiat. Oncol. Biol. Phys. 19, 1059-1065 (1990). (Pubitemid 20345181)
29. Dickesn C. Personalized fixation using a vacuum consolidation technique. Br. J. Radiol. 54, 257-258 (1981).
30. Wunderink W, Mendez Romero A, de Kruijf W, de Boer H, Levendag P, Heijmen B. Reduction of respiratory liver tumor motion by abdominal compression in stereotactic body frame, analyzed by tracking fiducial markers implanted in liver. Int. J. Radiat. Oncol. Biol. Phys. 71(3), 907-915 (2008). (Pubitemid 351749541)
31. No authors listed. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch. Intern. Med. 158(17), 1855-1867 (1998).
32. Mageras G, Yorke E. Deep inspiration breath hold and respiratory gating strategies for reducing organ motion in radiation treatments. Semin. Radiat. Oncol. 14, 65-75 (2004). (Pubitemid 38168955)
33. Wong J, Sharpe M, Jaffray D et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int. J. Radiat. Oncol. Biol. Phys. 44, 911-919 (1999). (Pubitemid 29284142)
34. Ford E, Mageras G, Yorke E et al. Respiration-correlated spiral CT: a method of measuring respiratory-induced anatomic motion for radiation treatment planning. Med. Phys. 30, 88-97 (2003). (Pubitemid 36106012)
35. Ozhasoglu C, Saw C, Hungcheng C et al. Synchrony - cyberknife respiratory compensation technology. Med. Dosim. 33(2), 117-123 (2008). (Pubitemid 351626572)
36. Grigsby PW, Heydon K, Mutch DG, Kim RY, Eifel P. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int. J. Radiat. Oncol. Biol. Phys. 51(4), 982-987 (2001). (Pubitemid 33026428)
37. Varia MA, Bundy BN, Deppe G et al. Cervical carcinoma metastatic to paraaortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int. J. Radiat. Oncol. Biol. Phys. 42(5), 1015-1023 (1998). (Pubitemid 29004143)
38. Mundt A, Murphy K, Rotmensch J, Waggoner S, Yamada S, Connell P. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 50(5), 1154-1160 (2001). (Pubitemid 32727791)
39. Higginson D, Morris D, Jones E, Clarke-Pearson D, Varia M. Stereotactic body radiotherapy (SBRT): technological innovation and application in gynecologic oncology. Gynecol. Oncol. 120(3), 404-412 (2011).
40. Deodata F, Macchia G, Grimaldi L et al. Stereotactic radiotherapy in recurrent gynecological cancer: a case series. Oncol. Rep. 22(2), 415-419 (2009).